Birdwatch Note
2024-10-22 22:57:18 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Novavax does not utiliz an mRNA platform, their vaccines are recombinant proteins expressed as nanoparticles or with and adjuvant. https://www.novavax.com/what-we-do/recombinant-protein-based-nanoparticle-vaccine-technology
Written by 1807E0ED63986FB55842E2FCBA31C29EE6352D3006C06F19B2F3FC8E820398D3
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1848857750195028257
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1848861214329475364
- noteId - 1848861214329475364
- participantId -
- noteAuthorParticipantId - 1807E0ED63986FB55842E2FCBA31C29EE6352D3006C06F19B2F3FC8E820398D3
- createdAtMillis - 1729637838333
- tweetId - 1848857750195028257
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Novavax does not utiliz an mRNA platform, their vaccines are recombinant proteins expressed as nanoparticles or with and adjuvant. https://www.novavax.com/what-we-do/recombinant-protein-based-nanoparticle-vaccine-technology
Note Ratings
| rated at | rated by | |
| 2024-10-25 04:14:57 -0500 | Rating Details | |
| 2024-10-24 18:46:40 -0500 | Rating Details | |
| 2024-10-22 22:06:09 -0500 | Rating Details | |
| 2024-10-22 21:50:46 -0500 | Rating Details | |
| 2024-10-22 21:11:10 -0500 | Rating Details | |
| 2024-10-22 20:51:40 -0500 | Rating Details | |
| 2024-10-22 20:50:06 -0500 | Rating Details | |
| 2024-10-22 19:56:14 -0500 | Rating Details | |
| 2024-10-22 19:31:06 -0500 | Rating Details | |
| 2024-10-22 18:30:48 -0500 | Rating Details | |
| 2024-10-28 22:17:04 -0500 | Rating Details | |
| 2024-10-26 02:00:39 -0500 | Rating Details | |
| 2024-10-22 21:22:03 -0500 | Rating Details | |
| 2024-10-22 20:47:13 -0500 | Rating Details | |
| 2024-10-22 20:38:35 -0500 | Rating Details | |
| 2024-10-22 20:09:57 -0500 | Rating Details | |
| 2024-10-22 20:08:35 -0500 | Rating Details | |
| 2024-10-22 19:09:01 -0500 | Rating Details | |
| 2024-10-29 02:26:16 -0500 | Rating Details | |
| 2024-10-23 13:50:40 -0500 | Rating Details | |
| 2024-10-23 00:30:17 -0500 | Rating Details | |
| 2024-10-22 21:54:40 -0500 | Rating Details | |
| 2024-10-22 20:58:51 -0500 | Rating Details | |
| 2024-10-22 20:38:45 -0500 | Rating Details | |
| 2024-10-22 20:10:06 -0500 | Rating Details | |
| 2024-10-22 20:02:51 -0500 | Rating Details | |
| 2024-10-22 19:20:37 -0500 | Rating Details | |
| 2024-10-22 19:17:55 -0500 | Rating Details | |
| 2024-10-23 11:11:47 -0500 | Rating Details | |
| 2024-10-23 09:59:40 -0500 | Rating Details | |
| 2024-10-22 19:46:20 -0500 | Rating Details | |
| 2024-10-22 19:35:31 -0500 | Rating Details | |
| 2024-10-22 19:23:42 -0500 | Rating Details | |
| 2024-10-22 18:32:31 -0500 | Rating Details | |
| 2024-10-22 18:13:21 -0500 | Rating Details | |
| 2024-10-23 14:41:57 -0500 | Rating Details | |
| 2024-10-22 20:57:23 -0500 | Rating Details | |
| 2024-10-22 20:54:37 -0500 | Rating Details | |
| 2024-10-22 20:34:54 -0500 | Rating Details | |
| 2024-10-22 20:21:53 -0500 | Rating Details | |
| 2024-10-22 19:58:45 -0500 | Rating Details | |
| 2024-10-22 19:40:34 -0500 | Rating Details | |
| 2024-10-22 19:39:22 -0500 | Rating Details | |
| 2024-10-22 19:18:16 -0500 | Rating Details | |
| 2024-10-22 18:32:39 -0500 | Rating Details | |
| 2024-10-22 18:21:42 -0500 | Rating Details |